Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Jordi Bach Taña
Introduction
Jordi Bach Taña is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that serve as inhibitors of Janus Kinases (JAK). With a total of 3 patents to his name, Taña's work is paving the way for advancements in therapeutic treatments.
Latest Patents
Among his latest patents, Taña has developed substituted pyrazolo[1,5-a]pyridines as JAK inhibitors. These new pyrazole derivatives, characterized by their unique chemical structure, are disclosed along with the processes for their preparation, pharmaceutical compositions, and their therapeutic uses. Additionally, he has introduced new imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives, which also serve as JAK inhibitors, showcasing his innovative approach to drug development.
Career Highlights
Jordi Bach Taña is currently associated with Almirall, S.A., a leading pharmaceutical company. His work at Almirall has allowed him to focus on research and development, contributing to the advancement of new therapeutic options in the market. His expertise in medicinal chemistry and pharmacology has been instrumental in his success as an inventor.
Collaborations
Throughout his career, Taña has collaborated with notable colleagues, including Lluis Miquel Pages Santacana and Paul Robert Eastwood. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new pharmaceutical compounds.
Conclusion
Jordi Bach Taña's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to influence the development of new therapies that can improve patient outcomes.